Treatment of Cyclophosphamide-Induced Cystitis with Prostaglandin E2

  1. J. MOHIUDDIN;
  2. H.G. PRENTICE;
  3. S. SCHEY;
  4. H. BLACKLOCK; and
  5. P. DANDONA
  1. Royal Free Hospital and School of Medicine;
    London NW3, 2QG
    , United Kingdom

    Excerpt

    To the editor: High-dose cyclophosphamide chemotherapy can be complicated by haemorrhagic cystitis, probably due to the effect of acrolein, a breakdown product, on the urothelium. The cystitis is occasionally fatal (1). The concurrent use of mesna (sodium 2-mercaptoethanesulphonate) has decreased the incidence of this complication (2). We report here the successful use of topical prostaglandin E2 (dinoprostone) in controlling severe chronic haemorrhagic cystitis after cyclophosphamide therapy to condition a bone marrow transplant recipient.

    An 18-year-old Iranian man had bone marrow transplantation for acute myeloid leukaemia during a refractory central nervous system relapse. On the fourth and third days before transplantation,

    This 100-word excerpt has been provided in the absence of an abstract.

    « Previous | Next Article »Table of Contents